9Schmidt—wolf I G H.Negrin R S.Kiem H P.et al.Use of a SCID mouse／Human lymphoma model to evaluate cytokineinduced killer cells with potent antitumor cell activity[J].J Exp Med,1991,174:139～149.
10Lu P H,Negrin R S. A novel population of expanded human CD3^+CD56^+ cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency[J]. J Immunol, 1994,153 : 1687-1696.
3Jing-Ting Jiang, Chang-Ping Wu, Lu-Jun Chen, Xiao Zheng, Department of Tumor Biological Treatment, Third Affiliated Hospital of Soochow University, Changzhou 213003, Jiangsu Province, China Yi-Bei Zhu, Jing Sun, Xue-Guang Zhang, Key Laboratory of Stem Cell of Jiangsu Province, Institute of Biotechnology, Key Laboratory of Clinical Immunology of Jiangsu Province, Soochow University, Suzhou 215123, Jiangsu Province, China Yue-Ping Shen, Wen-Xiang Wei, Department of Medicine, Soochow University, Suzhou 215123, Jiangsu Province, China Bin-Feng Lu, Department of Immunology, University of Pitts- burgh School of Medicine, Pittsburgh, PA 15261, United States.Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients[J].World Journal of Gastroenterology,2010,16(48):6155-6162. 被引量：83
